期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 29, 期 15, 页码 1968-1973出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2019.05.034
关键词
Calpain inhibition; Cysteine protease inhibition; Ketoamide; Alzheimer's Disease
资金
- AbbVie
Aberrant activation of calpain has been observed in various pathophysiological disorders including neurode-generative diseases such as Alzheimer's Disease. Here we describe our efforts on ketoamide-based 1-benzyl-5-oxopyrrolidine-2-carboxamides as a novel series of highly selective calpain inhibitors mitigating the metabolic liability of carbonyl reduction. The most advanced compound from this new series, namely A-1212805 (ABT-957, Alicapistat) proceeded to clinical phase I studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据